Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
about
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomasWhat a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathwayGenomic-Wide Analysis with Microarrays in Human OncologyThe determinants of head and neck cancer: Unmasking the PI3K pathway mutationsMacrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.Prognostic implications of PIK3CA amplification in curatively resected liposarcomaPIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinomaGenetic and epigenetic characterization of the tumors in a patient with a tongue primary tumor, a recurrence and a pharyngoesophageal second primary tumorIdentification of genomic copy number variations associated with specific clinical features of head and neck cancer.Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.Tumors of the upper aerodigestive tract
P2860
Q24336818-ED741CC9-49AA-43F2-9120-4CF9848913DDQ26825780-5827E5B0-13E1-4804-A32A-C089671B7A50Q28081059-D784ABEC-E70C-4DC3-A5A1-977F045C94C4Q30365726-6329FA24-C636-4CF4-819D-3A2A81FDC99AQ33752376-E856C25D-A2E9-4C7E-B836-64132AB6E810Q34436470-5C8A06EA-2900-4388-BA2C-749279565D3FQ35068192-4402292D-1646-4A32-B2E3-E6CCF72FE200Q35651134-0802CBCD-B1C3-4B96-8C8B-FE8897D36310Q36510237-F83ED441-4138-4CF2-B42F-9B329C76CCC2Q37164556-6BC96CCD-2876-4F14-B66C-DC4CA9F12387Q37269360-BF8362E3-E371-4678-B95B-E9992D26B6E4Q37327580-2CF557D8-6AFA-4880-8583-ED2566D82D92Q37706353-6521A725-B697-44F3-914F-FAE828606141Q38087239-176A3DD4-7195-47C7-9C23-908927652A8DQ38161944-53ADC2D7-9887-49A6-A653-34B152682EF2Q38245688-90FC0D36-2D76-4FA2-B0A3-C45F64D6D9FCQ38645307-EB472C41-AC63-492E-9405-BE1AB328C236Q39050475-DCFD79BC-DAD6-4638-B609-0FB95B2575F5Q41838545-0E540653-454A-4675-A076-D83E7C3689C9Q42026346-6C860A76-B088-415C-9B30-A35BD7462526Q48162253-182EE4DF-49D8-4569-BC6E-81E23AD71CA2Q53187961-65602A43-8426-4C49-B7B6-ACFAB6E42A11Q53206186-E6AA8F34-6D82-4B46-B137-6A8374A96B97Q58426138-B60248C8-5A3D-40D0-A720-44DEE37ADAAE
P2860
Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Copy number amplification of t ...... neck squamous cell carcinoma.
@ast
Copy number amplification of t ...... neck squamous cell carcinoma.
@en
type
label
Copy number amplification of t ...... neck squamous cell carcinoma.
@ast
Copy number amplification of t ...... neck squamous cell carcinoma.
@en
prefLabel
Copy number amplification of t ...... neck squamous cell carcinoma.
@ast
Copy number amplification of t ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Copy number amplification of t ...... neck squamous cell carcinoma.
@en
P2093
Hiroshi Moriyama
Mamoru Yoshikawa
Mitsuyoshi Urashima
Takakuni Kato
Takanori Hama
Toshihito Suda
P2860
P2888
P356
10.1186/1471-2407-12-416
P407
P50
P577
2012-09-20T00:00:00Z
P5875
P6179
1049491068